Growth Hormone Inhibits Activation of Phosphatidylinositol Phospholipase C by Insulin in ob/ob Mouse Adipose Tissue*
- 1 January 1990
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 126 (1) , 62-66
- https://doi.org/10.1210/endo-126-1-62
Abstract
The cellular mechanism(s) by which GH produces insulin resistance in peripheral tissues is poorly understood. Recent evidence suggests that insulin exerts certain of its intracellular actions by rapidly activating phosphatidylinositol-specific phospholipase C(s) (PI-PLC) in the plasma membranes of target cells. Therefore, the present study was conducted to determine whether insulin can activate PI-PLC in adipose tissue of the genetically obese (ob/ob) mouse, an animal that responds markedly to GH with enhanced peripheral insulin resistance. Also experiments were performed to determine whether the activation of PI-PLC by insulin could be blocked by S-carboxymethylated human GH (RCM-hGH), a GH derivative possessing mainly diabetogenic activity. Isolated adipose segments were incubated for various periods with insulin (10 mU/ml), homogenized and centrifuged to obtain a 150,00 .times. g pellet, and the latter was assayed for the ability to produce [3H]inositol phosphatidyl[3H]inositol. PI-PLC activity was significantly stimulated 5 min after exposure of the segments to insulin. By 10 min, the insulin effect was no longer apparent, and after 30 min, insulin reduced the activity of the enzyme. One hour after exposure to insulin, PI-PLC activity returned to the control level. When adipose segements of RCM-hCH-treated mice (200 .mu.g.day for 3 days sc) were incubated for 5 min with insulin, the ability of insulin to activate PI-PLC was abolished. However, RCM-hGH did not alter basal PI-PLC, indicating that its action involves the mechanism by which the enzyme is activated by insulin. Also, studies utilizing acute RCM-hGH treatment showed that its inhibitory effect on insulin activation of PI-PLC occurs within the same time frame as the onset of enhanced insulin resistance in the adipose tissue. Thus, the ability of GH to inhibit the activation of PI-PLC by insulin in adipocytes may account, at least in part, for its ability to induce insulin resistance in these cells.This publication has 14 references indexed in Scilit:
- Metabolic Basis for the Diabetogenic Action of Growth Hormone in the Obese (ob/ob) Mouse*Endocrinology, 1987
- Insulin-stimulated diacylglycerol production results from the hydrolysis of a novel phosphatidylinositol glycan.Journal of Biological Chemistry, 1987
- Insulin provokes a transient activation of phospholipase C in the rat epididymal fat pad.Journal of Biological Chemistry, 1986
- Insulin Stimulation of Glucose Metabolism in Rat Adipocytes: Possible Implication of Protein Kinase C*Endocrinology, 1986
- The de novo phospholipid effect of insulin is associated with increases in diacylglycerol, but not inositol phosphates or cytosolic Ca2+Biochemical Journal, 1985
- Rapid effects of phorbol esters on isolated rat adipocytes. Relationship to the action of protein kinase CEuropean Journal of Biochemistry, 1985
- Reduced and S-carboxymethylated human growth hormone: a probe for diabetogenic actionAmerican Journal of Physiology-Endocrinology and Metabolism, 1984
- Effects of insulin and protein synthesis inhibitors on phospholipid metabolism, diacylglycerol levels, and pyruvate dehydrogenase activity in BC3H-1 cultured myocytes.Journal of Biological Chemistry, 1984
- Diabetogenic activity of native and biosynthetic human growth hormone in obese (ob/ob) mouseAmerican Journal of Physiology-Endocrinology and Metabolism, 1984
- Phosphatidic acid and phosphatidylinositol labelling in adipose tissue. Relationship to the metabolic effects of insulin and insulin-like agentsBiochemical Journal, 1983